News for hackers. Stuff that matters.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by setgree on Wednesday September 22, 2021 @03:24PM (#28620621)
Scott Alexander's "Adumbrations Of Aducanumab" is essential reading on this subject IMO [0].

He makes an interesting point that when the FDA approves a drug, it means that Medicare is automatically on the hook to pay for it, and that a more sensible system might decouple approval and mandated reimbursement by having multiple levels of approval (e.g. 1 star = this is probably safe, 2 stars = it's definitely safe, 3 = there's weak/controversial evidence for efficacy, 4 stars = it is safe and it works, etc.).

But it's interesting to me that we hear about FDA scientists resigning when a panel is too permissive, but not when it's too restrictive. Can we chalk this up to something about the kind of people the FDA recruits? I can recall just one instance of an FDA official pushing the institution to go faster, and that was when the doctor's wife died of cancer [1].

[0] https://astralcodexten.substack.com/p/adumbrations-of-aducan...

[1] https://www.nytimes.com/2016/01/03/us/politics/fda-regulator...

Re:Experts Have Resigned from an FDA Committee over Alzheime... by Brakenshire on Wednesday September 22, 2021 @04:17PM (#28621204)
We do have to make drug discovery vastly more efficient, but we want to make it more efficient at making useful drugs available, not just making drugs available. If you decouple availability from effectiveness then drug companies will just market unproven drugs to people who are desperate or who don't know any better. Or even if the drug companies do nothing people will just start taking drugs on the basis of recommendations from Facebook.

Maybe that means building randomized trials into treatment in a much more regular way (like with the Covid RECOVERY trials, where any doctor could enroll patients with a web form, and source the candidate treatment from the local pharmacy), which vastly reduces cost for treatments already on the market with other indications. And perhaps altering the balance of risk for patients with life-threatening or terminal diseases.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by civilized on Wednesday September 22, 2021 @04:35PM (#28621425)
One reason your proposal isn't happening today might be because we don't want tons of doctors choosing to enroll in these "field" randomized trials, if they might be experimentally treating people with drugs that aren't safe. We want to know about safety first before unleashing on the world, even in a randomized trial context. And since the FDA bundles verification of safety and efficacy together, so we can't do your proposal without unbundling them.

Now, imagine that after safety is verified to a 1 or 2-star level, we don't make the drug approved for general use, but doctors can freely enroll in randomized trials as you proposed? That way we're getting the efficacy data quickly but safely.

Maybe a minor point, but we do have to unbundle safety from efficacy in some sense to get off the ground here. The question is, what exactly is allowed to happen after safety is established but efficacy is not yet established?

Re:Experts Have Resigned from an FDA Committee over Alzheime... by Brakenshire on Wednesday September 22, 2021 @05:30PM (#28622109)
I agree, that's well put and I think that could work very well.

I think the key would be having clear centralized standards for how the trials are conducted, or you could have doctors skirting the system and just using it as de-facto prescription, and patients being put at risk for ineffective treatment without producing any valid evidence.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by civilized on Wednesday September 22, 2021 @06:06PM (#28622593)
Yeah, if the existing system is built on trust of doctors who run clinical trials, we have to ask whether that trust scales.

If the system were set up so that doctors would have a lot to lose if they didn't follow the system, trust could work here. We already trust doctors as professionals on many other things...

Re:Experts Have Resigned from an FDA Committee over Alzheime... by ezconnect on Wednesday September 22, 2021 @09:10PM (#28624117)
His proposal is to treat a new disease with approved drug you can buy and not experimental drugs. This will give us more data on therapies that might work and we can do more detailed studies on therapies with high percentage of recoveries.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by Sanguinaire on Wednesday September 22, 2021 @04:46PM (#28621553)
The problem here is letting drug companies market to the uneducated general public - there is a good reason why that practice is banned in most countries.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by irrational on Wednesday September 22, 2021 @04:55PM (#28621676)
Is it banned when it isn’t the drug companies doing the marketing to the uneducated general public? It wasn’t the drug companies telling uneducated people to use horse dewormer to combat Covid. That seems just as dangerous (probably more so) as drug companies making claims to the general public.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by wnissen on Thursday September 23, 2021 @11:57AM (#28631001)
Banned in every country, except the U.S. and New Zealand.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Wednesday September 22, 2021 @05:08PM (#28621838)
> If you decouple availability from effectiveness then drug companies will just market unproven drugs to people who are desperate or who don't know any better. Or even if the drug companies do nothing people will just start taking drugs on the basis of recommendations from Facebook.

But this already happens for certain treatments. The FDA already regulates a separate category with loose efficacy requirements for dietary supplements and herbal remedies. These medically irrelevant treatments are immensely popular, they're just forbidden from marketing specific medical claims and being actually toxic. People still end up taking FDA approved treatments like Ivermectin for non-FDA-approved purposes based on Facebook recommendations.

Why do we always have to make people's choices for them? They're grown adults capable of making their own decisions and their own mistakes. If they want to ignore the science and the credibility of the FDA process, they should be free to do so.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by dlp211 on Wednesday September 22, 2021 @07:42PM (#28623466)
> Why do we always have to make people's choices for them? They're grown adults capable of making their own decisions and their own mistakes. If they want to ignore the science and the credibility of the FDA process, they should be free to do so.

Because I am not a scientist and need an authoritative body that I can have some semblance of trust in to decide what medicine I can put in my body and a Dr can prescribe to me. And we have tried the unregulated route before and we had people taking cough syrup with heroine in it and other snake oils.

I mean, even with the FDA, we have people using animal dosage de-wormer to treat Covid with no evidence that it works and a lot of evidence that it will fuck up your guts...so as much as you want to play the "we're adults capable of making decisions" card, that statement really doesn't mean much in reality.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Wednesday September 22, 2021 @08:00PM (#28623620)
Is anyone even reading my comment or any of the comments above me? I'm not arguing against the FDA's safety requirements. The argument is for decoupling safety from efficacy requirements to make a treatment available to acquire. Right now availability is coupled with mandatory coverage by Medicare & insurance, which means treatments with borderline/controversial efficacy results like this Alzheimer one is either totally banned or mandatory for prescription & coverage. You wouldn't be able to sell heroin.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by HarryHirsch on Wednesday September 22, 2021 @11:03PM (#28624825)
decoupling safety from efficacy requirements to make a treatment available to acquire

That'll only serve to increase distrust in the FDA. Yeah, it's safe, but also, it's no good for anything. You wonder if that's the purpose of such initiatives, destroying trust in the public authorities to better be able to sell snake oil.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Wednesday September 22, 2021 @11:51PM (#28625033)
I'm sure that people who can read an FDA safety-only mark clearly labelled as safety-only will be just fine.

The benefits of separating them are relevant to this exact Alzheimer treatment; It has controversial efficacy, but now the FDA had to decide between "all doctors, insurance, and Medicare must cover/prescribe it" or "no one is allowed to do anything with it".

It will also serve to speed up the notoriously slow and expensive process to make something available and make grey-area treatments available. This completely fucked the FDA's early response to the initial need for COVID-19 testing kits. The FDA made a mistake as all organizations do, but its approval system is so inflexible it prevented many safe and realistically effective testing kits from being made available.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by kelnos on Wednesday September 22, 2021 @06:31PM (#28622856)
> Why do we always have to make people's choices for them? They're grown adults capable of making their own decisions and their own mistakes. If they want to ignore the science and the credibility of the FDA process, they should be free to do so.

Most people -- including myself -- are unequipped to evaluate the science behind most drugs. That supposed to be why the FDA exists. I do not want to make my own mistakes here, since they can very easily be fatal, or at least have long-term consequences. I want a trusted body of experts to give me a recommendation that's as well-informed and unbiased as possible. The FDA may or may not be as good as they should be at being that body, but it is absolutely needed.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Wednesday September 22, 2021 @07:27PM (#28623356)
This thread is about decoupling efficacy from safety, not releasing potentially fatal treatments. The whole point of Scott's article is that we can keep basic safety requirements but the efficacy requirements for FDA approval are much stricter and should be decoupled. The FDA can give a lower level of approval to treatments like this Alzheimer one that has controversial/borderline efficacy evidence instead of making a black & white choice between "not allowed at all" and "fully endorsed and must be covered by Medicare & insurance".

No one is arguing to get rid of safety requirements or the FDA. The FDA will still be empowered to give a recommendation based on efficacy, but the lack of an efficacy recommendation should not prevent people from getting a treatment. The FDA is necessarily conservative, slow, and sometimes makes mistakes. That has a real cost if it acts as the sole gatekeeper for efficacy, a prime example being early COVID-19 test kits.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by andrekandre on Wednesday September 22, 2021 @09:58PM (#28624441)
why would we want to sell drugs that are "safe" but ineffective?

imagine someone is in need of an effective treatment, but they don't like it or heard some rumors on tv or youtube, then instead they take an ineffective drug and think they aren't contagious, yet now they are potential spreaders of a disease... that doesn't sound safe at all to me.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Thursday September 23, 2021 @12:06AM (#28625117)
> why would we want to sell drugs that are "safe" but ineffective?

Because "ineffective" in your question actually means "not proven by the FDA to be effective" and the FDA, like all organizations, isn't perfect or perfectly responsive. For example, early COVID testing kits by third party labs that were safe and realistically effective but not yet approved. For example, this Alzheimer treatment that has controversial efficacy but the FDA could only choose between banning it completely or forcing insurance & Medicare to cover it.

We can make exceptions in scenarios where ineffective treatments have unusually high external risks such as the COVID-19 pandemic before effective vaccines were available. Now, someone who pays attention to the FDA can use an FDA approved vaccine to immunize themselves to the disease spread by people who make decisions based on YouTube rumors. Sounds safe enough to me. We each make our own choices.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by andrekandre on Thursday September 23, 2021 @06:04AM (#28627202)

  > We each make our own choices.
yes we do, but the caveat is, we dont live in isolation from one another, so in cases such as covid, people being able to take "proven safe but unknown effectiveness" medications is a recipe for unintentional spread to others... this is the opposite of safe imo
Re:Experts Have Resigned from an FDA Committee over Alzheime... by Brakenshire on Wednesday September 22, 2021 @05:38PM (#28622205)
One big reason is you're removing the economic incentive to produce good evidence. The herbal remedies industry is a perfect example, there will be valid treatments there but yet the industry is almost entirely medically useless. Some of the treatments might be effective for particular diseases, at particular doses but no one ever knows. These companies have billions in revenue and are vastly profitable but they never look for evidence that treatments work because people buy the remedies anyway, and a company that spent the money to run the trials would be undercut by less scrupulous competition. This is not even a market with asymmetry of knowledge, it's a market where no one knows anything, and the lack of regulation makes sure it continues that way.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Wednesday September 22, 2021 @05:45PM (#28622310)
There's still an economic incentive for the highest level of FDA approval: Medicare and insurance companies have to cover it and doctors can prescribe it. That ensures a high and consistent level of usage across the whole country, not just among people with more money than sense (usually IMHO; it's possible that they're just smarter & savvier than the notoriously conservative FDA, who knows, this is a big reason why taking away choice is bad on principle).

I don't think the lack of credible evidence of efficacy in the supplement market is for lack of trying. If an alternative medicine is actually effective, it just becomes medicine that the majority of people can trust and use.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by heavyset_go on Wednesday September 22, 2021 @06:06PM (#28622598)
> But this already happens for certain treatments. The FDA already regulates a separate category with loose efficacy requirements for dietary supplements and herbal remedies. These medically irrelevant treatments are immensely popular, they're just forbidden from marketing specific medical claims and being actually toxic.

In the US, supplements must be vitamins or minerals, botanical products, amino acids or enzyme products.

Drug companies can't develop a new compound and then try to sell it as a supplement unless it meets those requirements, which it probably won't, because drug companies rarely develop new compounds that are also found in nature or in your body already.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by setgree on Wednesday September 22, 2021 @06:14PM (#28622691)
To quote another SA piece, “the categories were made for man, not man for the categories” https://slatestarcodex.com/2014/11/21/the-categories-were-ma...

OP is saying we could change the laws that configure the distinction you draw.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by tsimionescu on Wednesday September 22, 2021 @11:07PM (#28624848)
> Why do we always have to make people's choices for them? They're grown adults capable of making their own decisions and their own mistakes. If they want to ignore the science and the credibility of the FDA process, they should be free to do so.

Because desperate sick people and their loved ones make excellent marks. Without standards, some doctor or medical company will milk every last penny from someone with the false promise of some sort of hope.

Not to mention second order effects. The more common it is for medicine to be seen not working, the more people will distrust the medical system.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by themacguffinman on Wednesday September 22, 2021 @11:36PM (#28624969)
A treatment that is safe but not proven by the FDA to be effective would not be part of the medical system (ie. doctors, insurance, Medicare), just an available and minimally safe product.

People are already "milked" on supplements and herbal remedies (which is at least still regulated to be safe, not necessarily true for a lot of informal quackery out there): people buy a lot of them without FDA approval or a medical prescription in the hopes that it somehow helps them. It's just fine. Rigorous FDA approval has & will always be available for people to use. They're grown adults, let them make that decision.

If people distrust the medical system because products outside the medical system have failed them, well, people are allowed to be stupid.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by andrekandre on Wednesday September 22, 2021 @09:54PM (#28624403)

  > They're grown adults capable of making their own decisions and their own mistakes.
in a society, "ones own mistakes" can have effects on those around you (e.g mask wearing, vaccine (not)taking, spreading misinformation etc) which can result in unintentional hospitalization or death of others

we dont live in isolated bubbles, so there is a limit to how far we can go with putting everything on the shelf and let everyone do what they want with it

Re:Experts Have Resigned from an FDA Committee over Alzheime... by jeherr on Wednesday September 22, 2021 @04:59PM (#28621722)
In regards to the panel being too restrictive or permissive, I think you have to look at the possible motivations for why. If you have a drug candidate that seems safe and effective, what possible motivation could the panel have for rejecting it? The pharma company gets their drug to market, patients get new and better drugs. The incentives are aligned so the issue with being too restrictive is a debate about how risky we should be approving new drugs.

On the other hand for a drug that’s safe but maybe not effective, there’s a lot of money to be made off of people willing to do anything to prolong their time with their loved ones who have been diagnosed with Alzheimer’s. Aside from that, the FDA can hurt it’s reputation by approving drugs that just don’t work too frequently and be accused of being in the pockets of the pharma companies. There’s a stronger possibility of corruption affecting the decision, and whether that corruption is real or perceived doesn’t matter much for public trust.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by cameronh90 on Wednesday September 22, 2021 @04:25PM (#28621307)
In the UK, as I understand it, we have:

MHRA: approval for marketing and sale within the UK

NICE: analyse cost/benefit ratio and safety profile for use within NHS (which is then approved by the NHS CCGs)

Re:Experts Have Resigned from an FDA Committee over Alzheime... by refurb on Wednesday September 22, 2021 @09:04PM (#28624077)
The FDA does have that option and is doing it for this drug. It’s called a “National Coverage Determination”

https://www.cms.gov/newsroom/press-releases/cms-opens-nation...

"Today, the Centers for Medicare & Medicaid Services (CMS) is opening a National Coverage Determination (NCD) analysis, a process that will allow the agency to carefully review and determine whether Medicare will establish a national Medicare coverage policy for monoclonal antibodies targeting amyloid for the treatment of Alzheimer’s disease."

Re:Experts Have Resigned from an FDA Committee over Alzheime... by AshamedCaptain on Wednesday September 22, 2021 @05:42PM (#28622252)
If there's weak evidence for the effectiveness of a drug, then most likely the drug has no effect at all. Let's remember that crap such as homeopathy would rank as 3 stars on your proposed system.

Our current research/science publishing system is not well suited to evaluating very small effects. Not that there may any system well suited to that.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by dougmwne on Wednesday September 22, 2021 @07:50PM (#28623540)
Precisely. If I want to create weak evidence for a drug, I can just run a few dozen studies and statistics will take care of the rest. Drugs with real, but very small effects are also not very useful as they aren't going to move the needle much, and certainly not as much as the quite powerful placebo effect.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by danzk on Wednesday September 22, 2021 @07:25PM (#28623343)
Government programs need to be able to negotiate drug prices to get a fair deal before subsidising them.

Whenever a trade deal comes up between the US and Australia, they always want to kill our PBS system that negotiates lower drug prices with pharmaceutical companies.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by usefulcat on Wednesday September 22, 2021 @05:21PM (#28621980)
Perhaps we need a third level of FDA approval. In addition to 'approved' and 'not approved', we could have 'safe but not demonstrated to be effective'. Drugs in the third category would be legal to prescribe but Medicare and insurance companies would not be required to pay for them.

Although in practice I guess this would probably not be very different from 'not approved', in which case it seems right for the FDA to reject ineffective drugs.

In any case, one thing we definitely do not want is to incentivize the creation of ineffective drugs, especially expensive ones.

Re:Experts Have Resigned from an FDA Committee over Alzheime... by dougmwne on Wednesday September 22, 2021 @07:43PM (#28623477)
What on earth would be the point of that? Why should we encourage the development of new snake oil? Why encourage drug companies, which currently must provide evidence their drugs work, to pivot into snake oil? Do you think we are an enlightened people immune from the snake oil our ancestors used to fall for? Recent pandemic events would beg to differ!
Re:Experts Have Resigned from an FDA Committee over Alzheime... by s1artibartfast on Wednesday September 22, 2021 @08:31PM (#28623864)
I think the point would be "safe but efficacy TBD" and be coupled with extensive monitoring until efficacy is either confirmed or denied. I think this is the general goal of the approval, but our reimbursement system is not set up to handle it because it doesn't take the level of benefit into account. Federal reimbursement is set at what the company wants, even if the product provides better or worse treatment than the alternative.
Re:Experts Have Resigned from an FDA Committee over Alzheime... by dougmwne on Thursday September 23, 2021 @04:17AM (#28626530)
"Safe but Efficacy TBD" is a phase 3 clinical trial. And measuring out the level of benefit vs. the cost to medicare is a totally different issue, I think. At that point, we know it works, and it deserves an approval. I think that's where these laws around publishing prices come in. No individual is going to be able to interpret them, and not even doctors were aware of what their treatments cost. But having the prices published gives advocacy organizations a chance to run the numbers of effect size vs treatment cost and point out areas where the cost is extortionate.

It could also be pretty awesome if there was a labeling requirement on all FDA approved drugs for effect size, from a red "not very effective" to a yellow "moderately effective" to green "highly effective".

Re:Experts Have Resigned from an FDA Committee over Alzheime... by s1artibartfast on Thursday September 23, 2021 @10:01AM (#28629271)
>"Safe but Efficacy TBD" is a phase 3 clinical trial.

I think you miss the point of the parent post. The point would be to allow drug companies to sell drugs that are reasonably safe, but efficacy is unknown. This would allow drugs and products to come to patients quicker, in a way that is decoupled from reimbursement.

>It could also be pretty awesome if there was a labeling requirement on all FDA approved drugs for effect size, from a red "not very effective" to a yellow "moderately effective" to green "highly effective".

You are in luck! The FDA has what are literally called "Labeling Requirements" for all approved drugs, which includes a description effect sizes and side effects. You can find the effect sizes by searching "Prescribing information [Drug Name]". It doesn't include a color code, but does have "X% of patients had Y effect, Z% of patients had N effect, ect"

Re:Experts Have Resigned from an FDA Committee over Alzheime... by dougmwne on Thursday September 23, 2021 @12:26PM (#28631386)
I am definitely missing the point of allowing nonfunctional drugs to be sold and advertised as curing anything. What keeps me from selling magic molecule pills and advertising that they are approved for safety and in trials to cure cancer? And even if you disallow advertisements for drugs not yet proven effective, what's to stop my magic molecule pills from going viral and making me a whole lot of money on something I know is extremely unlikely to treat any disease, because I literally put a random inert molecule in there?
Re:Experts Have Resigned from an FDA Committee over Alzheime... by s1artibartfast on Thursday September 23, 2021 @01:42PM (#28632489)
The problem that this could address is the FDA is slow and has an all or nothing approach. This means:

1) Timing: There are people who suffer and die while products are held up in lengthy phase 3 approvals. 2) Human Impact: There are drugs& devices which are safe, but have weak efficacy data. For some like aducanumab, if they work, they could help millions of people today. This puts the FDA in a tough spot weighing a big potential benefit to society against things medicare costs for a low/no efficacy drug.

Im personally not advocating for throwing open the gates to any snake oil. I think a reasonable proposal would be to require robust data on safety, a strong argument for why it should work, and require monitoring of efficacy after approval.

If time tells that your magic pills dont work, they get pulled from the market. If time tells that they do work, you get your gold star

The first link in this post explains it better than I can.

https://news.ycombinator.com/item?id=28620621

Re:Experts Have Resigned from an FDA Committee over Alzheime... by s1artibartfast on Wednesday September 22, 2021 @09:03PM (#28624070)
Great read, thanks!
Re:Experts Have Resigned from an FDA Committee over Alzheime... by mchusma on Wednesday September 22, 2021 @05:51PM (#28622384)
Here here. People at the FDA should be resigning over them banning the COVID vaccine for kids under 12, for example. But we don't see behavior like that.

It's just a sign that the FDA is so horribly broken, it probably can't be recovered.

One note that I think would be important is that we should stop using the term "approved" or "not approved" and instead used "banned" or "not banned", as this is a more clear way to describe the situation. For example, in Sep 2020, it was completely obvious that taking a covid vaccine if you were elderly was dramatically better than waiting for COVID. But you could not, because the government said no. It didn't matter how informed you were, how much your doctor would agree, the answer was no. You go to jail if you try to take it. That should be called "banned".